Letter/Comment
The latest advocacy letters and comments from the American Hospital Association.
We concur with the DEA that setting quotas for the production of opioid medications can be an effective step in “preventing the accumulation of controlled substances in amounts exceeding legitimate need,” and therefore reduce the chance that these powerful medications will be diverted for non-…
AHA's comments on the Centers for Medicare & Medicaid Services’ and its contractors’ draft specifications for the two transfer of health information measures under development.
AHA responds to the US Department of Treasury Office of Tax Policy request for guidance on questions raised by new tax law.
AHA letter to FCC regarding concern about the unexpected and significant funding cuts for the Rural Health Care (RHC) program participants, announced in March by the Universal Service Administrative Company (USAC), the program administrator.
AHA comments to CMS on the proposed rule amending the definition of short-term, limited-duration health insurance.
AHA comments to the House Subcommittee on Health Energy and Commerce on bills related to the opioid crisis.
As the nation continues to struggle with the devastating public health crisis created by the opioid epidemic, it is encouraging to see the Committee on Health, Education, Labor & Pensions take constructive action. The American Hospital Association (AHA) appreciates your interest and…
AHA reiterates support for legislation to align 42 CFR Part 2 with HIPAA.